Skip to main content
logo
Solvonis Therapeutics plc (LON:SVNS)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
0.1000
+0.0075 (8.11%)
Nov 5, 2026, 4:35 PM GMT

Solvonis Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7215114-
Market Cap Growth
-67.95%348.30%686.33%-95.86%--
Enterprise Value
6195011-
Last Close Price
0.000.000.000.010.14-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---1.0226.70-
PB Ratio
1.423.411.530.303.18-
P/TBV Ratio
-40.274.73-5.82-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---0.2021.08-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.01-0.020.011.18
Net Debt / Equity Ratio
-0.12-0.27-0.24-0.06-0.350.44
Net Debt / EBITDA Ratio
--0.560.050.62-0.23
Net Debt / FCF Ratio
0.180.500.670.080.53-0.82
Asset Turnover
---0.160.13-
Inventory Turnover
---3.75--
Quick Ratio
1.183.696.610.634.740.32
Current Ratio
1.184.006.850.815.880.32
Return on Equity (ROE)
-94.61%-123.77%-56.63%-94.83%-100.82%-
Return on Assets (ROA)
-26.57%-41.42%-33.44%-40.62%-41.84%-
Return on Capital Employed (ROCE)
-58.70%-50.30%-48.90%-117.00%-59.10%-199.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-82.10%-27.20%-33.78%-521.25%-18.69%-
FCF Yield
-48.87%-15.51%-24.01%-242.92%-21.27%-
Buyback Yield / Dilution
-160.12%-320.56%-1011.63%-0.45%-47.98%-1.45%